En español
NIDA

Advancing Psychiatric Practice through the Science of Addiction

Special NIDA research track at the American Psychiatric Association's annual conference

May 07, 2013

The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, will present a special research track at the American Psychiatric Association’s (APA’s) 166th annual meeting in San Francisco from May 18 to 22. The NIDA sessions will highlight a wide range of topics to advance psychiatric practice through addiction science.

WHAT: Advancing Psychiatric Practice Through the Science of Addiction
NIDA special research track at the APA 166th annual meeting

WHEN: Saturday, May 18 – Wednesday, May 22, 2013

WHERE: Moscone Convention Center
www.moscone.com/pdf/MosconeParkingMap.pdf
San Francisco, Calif.

HIGHLIGHTS:

  • APA’s Opening Press Conference.
    During this opening press event and meeting overview, NIDA director Dr. Nora D. Volkow will provide a brief summary of the NIDA sessions.
    Saturday, May 18; 8:30 – 9:30 a.m.
    Yerba Buena Salon 1-3, Marriott Marquis Hotel, 55 Fourth Street
  • Addiction Performance Project. 
    Award-winning actress Mare Winningham leads an impressive cast in this innovative continuing medical education (CME) program, designed to help physicians incorporate screening, brief intervention, and referral to treatment. More information:www.drugabuse.gov/nidamed/about-addiction-performance-project/upcoming-performance-detailscme-ce-information/may-2013-san-francisco-ca.
    Sunday, May 19; 2 – 4 p.m.
    Room 130/131, Moscone Convention Center (North Building)
  • Frontiers of Science Lecture – Substance Use Disorders: New Scientific Findings and Therapeutic Opportunities.
    Dr. Volkow speaks on new findings and future directions for the treatment of substance use disorders.
    Monday, May 20; 11 a.m. – 12:30 p.m.
    Gateway Ballroom 102/103, Moscone Convention Center (South Building)
  • Evolutionary Explorations of the Human Genome.
    Special lecturer, Dr. Robert K. Moyzis from the University of California, Irvine, explores evolutionary implications of the human genome.
    Tuesday, May 21; 3:30 – 5 p.m.
    Gateway Ballroom 102/103, Moscone Convention Center (South Building)

OTHER NIDA SESSIONS:

  • Smoking Cessation in Patients with Severe Mental Illness: New Research Findings and Clinical Implications.
    Treating nicotine-dependent patients who have also been diagnosed with a substance use disorder or other mental disease.
  • Smoking and ADHD Comorbidity—Mechanisms and Clinical Implications.
    Nicotine use and cessation outcomes in smokers with ADHD.
  • Comorbid Psychiatric and Substance Use Disorders: Common and Specific Influences and Implications for Early Identification and Treatment.
    Common underlying mechanisms of and treatment for patients with co-occurring psychiatric and substance use disorders.
  • Advances in Pharmacotherapies for Substance Use Disorders.
    Current and future directions for medications to treat substance use disorders.
  • Cannabis Use and Youth: Updates on Risk, Assessment and Treatment.
    Effects of cannabis on the developing brain; screening and treatments for cannabis use disorders in youth.
  • Update on Prescription Opioid Abuse and Treatment Options for the Psychiatrist.
    Managing pain while limiting prescription opioid abuse in the psychiatric patient.

For more information on the APA annual meeting, visit http://annualmeeting.psychiatry.org/.

Contact:
NIDA Press Office
301-443-6245
media@nida.nih.gov

About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to drugpubs@nida.nih.gov. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH. . .Turning Discovery Into Health®

News Releases

2017

2016

2015

2014

2013

2012

2011

2010

Get this Publication

Cite this article

NIDA. (2013, May 7). Advancing Psychiatric Practice through the Science of Addiction. Retrieved from https://www.drugabuse.gov/news-events/news-releases/2013/05/advancing-psychiatric-practice-through-science-addiction

press ctrl+c to copy
Receive Latest Science Articles in your Email!
You will only receive messages related to Latest Science